Advanced Filters
noise

Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 463 clinical trials
y yves guilhermet, MD,PhD

Biological Bank for Atrial Fibrillation and Stroke

Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. This arrhythmia is responsible for 15% of strokes and more than 30% of strokes on people over 65 years. According to studies, 30 to 40% of isolated atrial fibrillations could be familial. Atrial fibrillation has significant genetic …

18 years of age All Phase N/A
S Shudong Xia, M.D.

Large Language Model and Atrial Fibrillation Recurrence

This study aims to develop a risk prediction model for atrial fibrillation (AF) recurrence by leveraging large language model (LLM) technology to analyze semantic relationships across multimodal textual data, including pre-ablation clinical baseline characteristics, echocardiography reports, ambulatory electrocardiogram reports, and procedural records. The proposed model seeks to provide actionable clinical …

18 - 90 years of age All Phase N/A
C Christine Rutan

Get With the Guidelines Atrial Fibrillation Registry

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further …

18 - 125 years of age All Phase N/A
D Daniel Engler, MSc.

Cohort Study for Atrial Fibrillation Risk Stratification

AFHRI is planned as a prospective, single-center cohort study in patients at high risk of AF.

18 - 85 years of age All Phase N/A
J Jan Niederdöckl, Dr.

Atrial Fibrillation at the Viennese University Emergency Department

The results of this study could imply that a atrial fibrillation registry, as a tool for structured diagnosis and therapy in patients with atrial fibrillation, may improve patient care for this rapidly growing population.

18 years of age All Phase N/A
K Krysten Gregus

DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

18 - 120 years of age All Phase N/A
K Konrad Pieszko, MD, PhD

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

The goal of this observational registry is to collect a curated dataset of multimodal imaging data that will serve for development of artificial-intelligence based solutions for prediction of risk and outcomes in patients with atrial fribrillation. Type of study: observational study Study Participants: Patients with atrial fibrillation or atrial flutter …

18 years of age All Phase N/A

PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation

Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood. The aim of the PROSPECT-AF study is to assess the predictors of AF recurrence within the 3 …

18 years of age All Phase N/A
C Carlo de Asmundis, MD, PhD

Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB …

18 - 85 years of age All Phase N/A
S Sylvie Lang, PhD

Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation

The aim of the present prospective study is to further develop and validate a composite risk score predicting both ischemic and bleeding risk, based on epidemiologic, clinical, biological, and/or morphologic complementary data. First, the investigators will assess the predictive performance of current clinical risk scores. Second, the investigators will assess …

18 years of age All Phase N/A

Simplify language using AI